Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [329]

Dual-targeting radiopharmaceutical therapy safe and effective across multiple cancers

Dual-targeting radiopharmaceutical therapy safe and effective across multiple cancers

Scientists develop super strong antibodies for new cancer treatment

Scientists develop super strong antibodies for new cancer treatment

Radioiodine therapy improves relative survival rates of differentiated thyroid cancer patients

Radioiodine therapy improves relative survival rates of differentiated thyroid cancer patients

Study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region

Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region

Vanessa Moss prize celebrates cancer health disparities research

Vanessa Moss prize celebrates cancer health disparities research

FDA approves dual-action drug for patients with previously treated advanced neuroendocrine tumours

FDA approves dual-action drug for patients with previously treated advanced neuroendocrine tumours

FDA approves cabozantinib for adults and peadiatric patients 12 years of age and older with pNET and epNET

FDA approves cabozantinib for adults and peadiatric patients 12 years of age and older with pNET and epNET

Metronomic chemotherapy: A promising approach for pediatric neuroblastoma

Metronomic chemotherapy: A promising approach for pediatric neuroblastoma

New research a step toward off-the-shelf CAR T cell therapy for cancer

New research a step toward off-the-shelf CAR T cell therapy for cancer

More from ecancer